Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?

Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?

Source: 
Motley Fool
snippet: 
  • Three of Johnson & Johnson's blockbusters are on Medicare's price negotiation list.
  • Drugmakers have filed court cases fighting the government's plan to directly negotiate prices.